Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients - Wikidata - awgldk - TriplyDB

Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients

Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients

http://www.wikidata.org/entity/Q24563395

about

Multiple sclerosis, relapses, and the mechanism of action of adrenocorticotropic hormone The pathology of multiple sclerosis and its evolution The voltage-gated potassium channel Kv1.3 is highly expressed on inflammatory infiltrates in multiple sclerosis brain Role of microglia in central nervous system infections Regulation of pulmonary fibrosis by chemokine receptor CXCR3 BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2 Involvement of beta-chemokines in the development of inflammatory demyelination Impact of Exercise on Innate Immunity in Multiple Sclerosis Progression and Symptomatology Computational Modelling Approaches on Epigenetic Factors in Neurodegenerative and Autoimmune Diseases and Their Mechanistic Analysis The Ins and Outs of B Cells in Multiple Sclerosis Pro-inflammatory functions of astrocytes correlate with viral clearance and strain-dependent protection from TMEV-induced demyelinating disease Chemokines and chemokine receptors: update on utility and challenges for the clinician.Control of autoimmune CNS inflammation by astrocytes Structure-function relationship between the human chemokine receptor CXCR3 and its ligands Plasma biomarkers discriminate clinical forms of multiple sclerosis Genetic variants of CC chemokine genes in experimental autoimmune encephalomyelitis, multiple sclerosis and rheumatoid arthritis Astrocytes in multiple sclerosis: a product of their environment The blood-brain-barrier in multiple sclerosis: functional roles and therapeutic targeting Hypoxia induces expression of the chemokines monocyte chemoattractant protein-1 (MCP-1) and IL-8 in human dermal fibroblasts Antigenicity and immunogenicity of allogeneic retinal transplants Identification and characterization of a potent, selective, and orally active antagonist of the CC chemokine receptor-1 CXCR3 blockade inhibits T-cell migration into the CNS during EAE and prevents development of adoptively transferred, but not actively induced, disease CXCL12-induced monocyte-endothelial interactions promote lymphocyte transmigration across an in vitro blood-brain barrier Chemokine network in multiple sclerosis: role in pathogenesis and targeting for future treatments.Microarray analysis identifies a set of CXCR3 and CCR2 ligand chemokines as early IFNbeta-responsive genes in peripheral blood lymphocytes in vitro: an implication for IFNbeta-related adverse effects in multiple sclerosis.An investigation of polymorphisms in the 17q11.2-12 CC chemokine gene cluster for association with multiple sclerosis in Australians.LRCH1 interferes with DOCK8-Cdc42-induced T cell migration and ameliorates experimental autoimmune encephalomyelitis.MDC/CCL22 intrathecal levels in patients with multiple sclerosis.Characterization of Th1- and Th2-associated chemokine receptor expression in spleens of patients with immune thrombocytopenia.A combined CXCL10, CXCL8 and H-FABP panel for the staging of human African trypanosomiasis patients Therapeutic targets and limits of minocycline neuroprotection in experimental ischemic stroke.Induction of the chemokines interleukin-8 and IP-10 by human immunodeficiency virus type 1 tat in astrocytes.Cyclopentenone prostaglandins PGA2 and 15-deoxy-delta12,14 PGJ2 suppress activation of murine microglia and astrocytes: implications for multiple sclerosis.A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica.Expression of chemokine receptors on peripheral blood lymphocytes in multiple sclerosis and neuromyelitis optica.Viral expression of CCL2 is sufficient to induce demyelination in RAG1-/- mice infected with a neurotropic coronavirus.Deletion of astroglial CXCL10 delays clinical onset but does not affect progressive axon loss in a murine autoimmune multiple sclerosis model A central role for CD4(+) T cells and RANTES in virus-induced central nervous system inflammation and demyelination Trafficking of immune cells in the central nervous system

P2860

Q21558407-54757100-90DA-4391-BCBF-2B72BD4433FA Q22242676-9EC2AA1B-3961-4AF6-ACD5-3D06FC930CE4 Q24534346-8B33EA5A-43F5-4325-AED4-CEDCF95904B6 Q24563024-3508ADBE-9955-4188-914E-50C64DCC5AB8 Q24563456-24D9792E-6FEB-4F86-862C-BDC9BCF13327 Q24646563-DED02F28-60E8-4710-880A-C93E92488CA1 Q24657388-7926FAA5-F06C-4BDB-8A46-14101DBF52AA Q24801279-7D5FD60F-B25D-44F9-BE7E-2715096FA4A7 Q26745562-6C4D21FF-A940-4E4F-96DB-1CAE6F1CFFAB Q26774368-86932B82-D843-4AA0-8E28-C21CED84D90F Q26776542-5E057A16-3182-4A01-93D5-93F7E248397A Q27486158-E0C980FE-368A-4B35-A217-328AC34DABE3 Q27687402-A0A21CBB-1A86-46FE-B8C4-236627398BC2 Q28084132-B2E6240E-88C1-4B53-8D7E-B14B994A3FBC Q28213616-9D0AE971-0D2E-4203-9754-1D9F5D0BD031 Q28262774-96CF51D8-2638-4AB9-9416-B69DE75B4BAC Q28262855-938203F3-A2EE-440F-8BF4-1ADAE8F39D8E Q28282324-5DA9F0CB-65F7-4435-913D-B764D0D70647 Q28299076-133C2D0B-AB19-4582-97C6-347B122BB8B5 Q28347182-2A24DB23-05C0-4961-8C02-3C89E2A92D57 Q28361839-7476380B-7F9F-4376-BEED-FE30381E5D0B Q28375207-01BDD227-3564-4C35-AA28-28695642B501 Q28578270-9B337EE5-6B57-44B9-A2B6-71D9846C118F Q30541389-366F56C3-F0A3-47D9-81DA-56D9BA4A37BD Q33214417-46E82325-45B9-4EF4-B56F-598525BE8FC4 Q33243924-CEFBF75B-80E4-4558-9CCD-3D0157580721 Q33252011-E988F016-B86E-4C2D-A6F2-D45854DBFB12 Q33289411-CF84FBCF-32D7-4D1C-8B71-DAE69EF4530E Q33315609-8651F027-49A1-4CC7-899A-E3F5802F8007 Q33406481-23AA83EA-B4AC-42D6-A154-DB1A9AD269FF Q33474338-894941F0-FDCC-40C9-9373-3A211FB66056 Q33508929-5D687690-56C1-4FD9-AB1B-3B8FA1705C77 Q33604853-DF219854-027F-4608-8B58-246B540406B3 Q33644063-1DC519DE-7DE0-4C1A-93B8-15737FD7172C Q33727402-C6140447-B2E0-4888-84C7-8C5E27751BC6 Q33743686-51976603-1BD6-4967-A57F-EEAD69A853FB Q33788907-96C350BD-73EF-488D-B57F-1A3148BA8CC6 Q33789063-215E3F9D-1B13-45A0-9B38-033554400A4E Q33793526-224CF686-68BF-4E8F-B8FE-907E51B6CBA7 Q33815795-F647008E-A62E-455F-96D5-DF753E364F32

P2860

Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients

http://www.wikidata.org/entity/Q24563395

description

1999 nî lūn-bûn

@nan

1999 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի մարտին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年学术文章

@wuu

1999年学术文章

@zh-cn

1999年学术文章

@zh-hans

1999年学术文章

@zh-my

1999年学术文章

@zh-sg

1999年學術文章

@yue

name

Expression of specific chemoki ...... of multiple sclerosis patients

@ast

Expression of specific chemoki ...... of multiple sclerosis patients

@en

Expression of specific chemoki ...... of multiple sclerosis patients

@nl

type

label

Expression of specific chemoki ...... of multiple sclerosis patients

@ast

Expression of specific chemoki ...... of multiple sclerosis patients

@en

Expression of specific chemoki ...... of multiple sclerosis patients

@nl

prefLabel

Expression of specific chemoki ...... of multiple sclerosis patients

@ast

Expression of specific chemoki ...... of multiple sclerosis patients

@en

Expression of specific chemoki ...... of multiple sclerosis patients

@nl

P1433

Q24563395-E355BFD2-55D1-4932-9686-2BB8D0C3D397

P1476

Q24563395-99FD93B5-8B90-47A4-9834-2EB19A999C13

P2093

Q24563395-17690363-D41D-4260-BB63-325796C560B6

Q24563395-36ED9578-4AA3-45E5-B5E1-BA9B79E3E111

Q24563395-3787F737-11B9-4764-819E-326A7A1D782B

Q24563395-3808589A-79EF-4551-A6A0-F024ED8D225D

Q24563395-536B8F52-8616-41F4-979D-A784059F4DD3

Q24563395-56AF8EEA-C5A6-4711-BC71-BCCF2600C3AF

Q24563395-653AFCC3-A15D-4374-9BC0-A7B474B58961

Q24563395-67AAF7CB-AEC4-4806-A68E-4D0248D5479A

Q24563395-72A7D372-E782-4551-ADD5-FF60A9D8BBF4

Q24563395-74589EC3-BC76-478C-AA78-69E82D761B2F

P2860

Q24563395-01612C84-585C-45A8-8CA6-909A5728C8EC

Q24563395-0C676309-0E49-4556-B3D7-F5074D9B1169

Q24563395-0E949A5E-35AB-4BCB-B900-73811C6A5A99

Q24563395-0F632661-AEF5-4DB1-B92B-5EF676D212D1

Q24563395-0FA92624-0BB9-4A35-AA96-EA119A177678

Q24563395-12DBCCE1-1C1B-4F34-B64C-6EDDC1214AD9

Q24563395-1E5F81C3-95FF-4181-99DF-5AA3B1A6CC7F

Q24563395-2026BC35-358B-40FD-ADB1-B27D7F4C0D1F

Q24563395-26AF4072-FBDE-4B6A-9A35-472E20D1C4BA

Q24563395-342932D3-CDB9-4382-A1BF-2EDF830F7B2A

P304

Q24563395-7D68D6F0-5ADC-47BD-BD08-69B16350F96F

P31

Q24563395-093E06A4-14D3-4B4F-B909-EE285ED54961

P3181

Q24563395-A9328141-864F-4B76-A7F6-7232C013860E

P356

Q24563395-6A29EEE7-13BB-4800-B768-E3C02AD43CBF

P407

Q24563395-DFB01BB7-5CAA-4516-9498-09108C1836C2

P433

Q24563395-4EDD656C-420B-4767-8256-9E6BF64995BE

P478

Q24563395-9F38D382-278B-4192-B602-64D2E17734D6

P577

Q24563395-5A610208-0F3A-410B-B59B-64F5235D6375

P698

Q24563395-DC356E78-8EA0-4F03-9E52-8C1B741F6B29

P921

Q24563395-88C079CE-4C4A-414B-A6E6-D938CDB48310

Q24563395-C21BED1A-50D6-4266-81F8-AFAAA6482B97

P932

Q24563395-853FABD1-E6D5-435F-9CE6-663C90B78F74

P3181

P356

P1433

Journal of Clinical Investigation

P1476

Expression of specific chemoki ...... of multiple sclerosis patients

@en

P2093

C Lucchinetti

http://www.w3.org/2001/XMLSchema#string

F Sellebjerg

http://www.w3.org/2001/XMLSchema#string

J Jensen

http://www.w3.org/2001/XMLSchema#string

J L Frederiksen

http://www.w3.org/2001/XMLSchema#string

J Rottman

http://www.w3.org/2001/XMLSchema#string

M Tani

http://www.w3.org/2001/XMLSchema#string

R M Ransohoff

http://www.w3.org/2001/XMLSchema#string

R M Strieter

http://www.w3.org/2001/XMLSchema#string

S Qin

http://www.w3.org/2001/XMLSchema#string

T L Sørensen

http://www.w3.org/2001/XMLSchema#string

P2860

Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells

Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes

The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions

Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity

Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP-1 in experimental autoimmune encephalomyelitis

Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis

Mig and IP-10: CXC chemokines that target lymphocytes

Axonal transection in the lesions of multiple sclerosis

Chemokines--chemotactic cytokines that mediate inflammation

P304

807-15

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1090999

http://www.w3.org/2001/XMLSchema#string

P356

10.1172/JCI5150

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

103

http://www.w3.org/2001/XMLSchema#string

P577

1999-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10079101

http://www.w3.org/2001/XMLSchema#string

P921

multiple sclerosis

P932

408141

http://www.w3.org/2001/XMLSchema#string